Eric David
2014
In 2014, Eric David earned a total compensation of $1.3M as Chief Strategy Officer and Executive Vice President of Pre-Clinical Development at ORGANOVO HOLDINGS.
Compensation breakdown
| Non-Equity Incentive Plan | $81,609 |
|---|---|
| Option Awards | $921,256 |
| Salary | $289,805 |
| Total | $1,292,670 |
David received $921.3K in option awards, accounting for 71% of the total pay in 2014.
David also received $81.6K in non-equity incentive plan and $289.8K in salary.
Rankings
In 2014, Eric David's compensation ranked 6,434th out of 13,032 executives tracked by ExecPay. In other words, David earned more than 50.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,434 out of 13,032 | 51st |
Division Manufacturing | 2,347 out of 4,966 | 53rd |
Major group Chemicals And Allied Products | 788 out of 1,686 | 53rd |
Industry group Drugs | 617 out of 1,365 | 55th |
Industry Biological Products, Except Diagnostic Substances | 119 out of 236 | 50th |
Source: SEC filing on July 8, 2016.
David's colleagues
We found four more compensation records of executives who worked with Eric David at ORGANOVO HOLDINGS in 2014.